Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Genmab A/S News

    28,10 $ +2,33% +0,64 $
    In : 26,262 € | 21:44:24 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1WZYB
    ISIN: US3723032062
    US-Symbol: GMAB
    Typ: Aktie

    Genmab A/S News

    09.12.23 - PR Newswire
    New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients with Difficult-To-Treat Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
    New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients with Difficult-​To-Treat Relapsed/Refractory (R/R) ...
    13.11.23 - PR Newswire
    Thinking about trading options or stock in Monday.Com, Boeing, Eli Lilly, Xpeng, or Genmab?
    Thinking about trading options or stock in Monday.Com, Boeing, Eli Lilly, Xpeng, or Genmab? PR Newswire
    13.04.22 - PR Newswire
    AbbVie and Genmab Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) from Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL)
    AbbVie and Genmab Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) from Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) ...
    09.09.21 - PR Newswire
    Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL) Published in The Lancet
    Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-​Hodgkin's Lymphoma (B-NHL) Published in The Lancet - ...
    26.03.18 - PR Newswire
    Genmab A/S webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference
    Genmab A/S webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference PR Newswire
    21.03.18 - PR Newswire
    International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on March 22, 2018
    International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on March 22, 2018 PR Newswire
    21.03.18 - PR Newswire
    Genmab A/S to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on March 22, 2018
    Genmab A/S to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on March 22, 2018 PR Newswire
    17.04.14 - PR Newswire
    GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based
    GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) as first-​line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) ...
    17.10.13 - PR Newswire
    OTCM ADR Index Up 11.12% in Q3 2013, 12.75% Year-to-Date
    OTCM ADR Index Up 11.12% in Q3 2013, 12.75% Year-​to-Date 67 companies joined Index in Q3, including AusTex Oil Limited, Dyesol Ltd., Invensys plc, Klabin S.A., QRxPharma ...

    Newssuche

    Videos

    08:40 Uhr +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »